Editor's Note Artificial intelligence (AI)-fueled analysis of electronic health records suggests that clinical guidelines for de-escalating surgery should be extended to younger breast cancer patients. Conducted by University of Pittsburgh and UPMC Hillman Cancer Center researchers and published in JCO Clinical Cancer Informatics, the analysis suggests that “surgery involving sentinel…
Editor's Note An AI model that outperformed MRI and ultrasound in identifying patients with axillary breast cancer metastasis shows the technology’s potential to reduce the need for needle or surgical biopsies, according to developers at UT Southwestern Medical Center. In a May 21 report on their new AI model, researchers…
Editor's Note A comprehensive systematic review and meta-analysis, published by JAMA Network on May 24 and encompassing 81 studies and over 24.9 million patients, shed light on the signs and symptoms associated with early-onset colorectal cancer (EOCRC) and highlighted significant delays in diagnosis. The analysis identified the most common presenting…
Editor's Note Nearly 7 in 10 physicians responding to a recent Wolters Kluwer Health survey report that their views on the healthcare benefits of generative artificial intelligence (AI) have shifted in a positive direction during the past year. Detailed in an April 16 report, the survey also reveals that 40%…
Editor's Note Microscopic stainless steel debris on the insides of biopsy needles prompted the FDA to issue a class 1 recall—indicating risk of death or serious injury—for Elekta Instrument’s Disposable Biopsy Needle Kit, which is used with the Leksell Stereotactic System for brain tissue sampling during neurosurgery, the disposable biopsy…
Editor's Note The US Food and Drug Administration (FDA) approved Lumisight (pegulicianine), a fluorescent imaging drug used to detect cancerous tissue during lumpectomy, on April 17. Administered intravenously prior to surgery, Lumisight is designed for use with the Lumicell Direct Visualization System (DVS) or another imaging device that is FDA-approved…
From integrating new technology to navigating shifts in care delivery and mitigating burnout, the most pressing challenges for healthcare organizations tend to be multifaceted problems that demand multifaceted solutions. For evidence of that, look no further than the Top 10 Patient Safety Concerns 2024 list from ECRI. For every risk…
Editor's Note Artificial intelligence (AI) is a useful tool for helping clinicians to determine health problems from medical imaging, but AI often provides just one answer, when there may be a number of possible interpretations. Now, researchers from MIT, the Broad Institute of MIT and Harvard, and Massachusetts General Hospital…
Editor's Note A new blood test developed by researchers in Australia could help diagnose sepsis and septic shock in just one hour, compared to the current multi-day methods. The Journal of Proteome Research reported the findings on March 21. Researchers collected blood plasma samples from 152 ICU patients. They used…
Editor's Note Patients with biliary symptoms can benefit from laparoscopic cholecystectomy even with a normal ejection fraction (greater than 35%), according to a study published November 30 in the American Journal of Surgery. Although previous data have shown the surgery to improve biliary symptoms (such as abdominal pain) in patients…